Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -66.51%374.09K | -54.68%429.85K | 66.97%1.06M | 63.38%2.44M | -277.82%-258.99K | 177.20%1.12M | 119.36%948.53K | 23.55%632.06K | 1.49M | 145.64K |
| Operating revenue | -66.51%374.09K | -54.68%429.85K | 66.97%1.06M | 63.38%2.44M | -277.82%-258.99K | 177.20%1.12M | 119.36%948.53K | 23.55%632.06K | --1.49M | --145.64K |
| Cost of revenue | -49.92%934.65K | -44.51%1.03M | 176.11%1.35M | 51.90%4.12M | -105.19%-90.23K | 475.50%1.87M | 517.90%1.85M | 40.79%487.42K | 2.71M | 1.74M |
| Gross profit | 25.18%-560.56K | 33.84%-597.8K | -300.83%-290.47K | -37.83%-1.68M | 89.41%-168.75K | -1,052.36%-749.23K | -781.11%-903.58K | -12.53%144.64K | -1.22M | -1.59M |
| Operating expense | 32.02%2.06M | 106.67%2.97M | 147.13%3.32M | -27.04%5.76M | 16.83%1.41M | -10.28%1.56M | -46.14%1.44M | -40.83%1.34M | -35.20%7.89M | -68.30%1.21M |
| Selling and administrative expenses | 41.91%1.39M | 237.53%2.34M | 177.16%2.56M | -9.80%3.49M | -1.91%889.76K | 20.35%981.12K | -41.60%694.57K | -3.42%923.76K | -12.31%3.87M | -29.04%907.13K |
| -General and administrative expense | 41.91%1.39M | 237.53%2.34M | 177.16%2.56M | -9.80%3.49M | -1.91%889.76K | 20.35%981.12K | -41.60%694.57K | -3.42%923.76K | -12.31%3.87M | -29.04%907.13K |
| Research and development costs | 15.29%668.78K | -15.47%629.09K | 81.09%760.8K | -43.62%2.27M | 73.43%523.31K | -37.24%580.1K | -49.77%744.2K | -68.05%420.13K | -48.19%4.02M | -88.10%301.75K |
| Operating profit | -13.47%-2.62M | -52.46%-3.57M | -201.16%-3.61M | 18.38%-7.43M | 43.56%-1.58M | -39.07%-2.31M | 7.74%-2.34M | 43.06%-1.2M | 25.21%-9.11M | 26.54%-2.8M |
| Net non-operating interest income (expenses) | -18.10%-142.97K | 30.93%-186.51K | 11.85%-154.42K | -185.61%-808.99K | -44.63%-242.72K | -62.05%-121.06K | -1,133.03%-270.02K | -926.24%-175.19K | -428.42%-283.25K | -1,223.40%-167.82K |
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Non-operating interest expense | 18.10%142.97K | -30.93%186.51K | -11.85%154.42K | 185.61%808.99K | 44.63%242.72K | 62.05%121.06K | 1,133.03%270.02K | 830.48%175.19K | 428.42%283.25K | 1,223.40%167.82K |
| Other net income (expenses) | -210.82%-5.26K | 99.94%-4 | -436.32%-18.68K | -2,895.33%-602.31K | -2,916.14%-590.88K | -401.78%-1.69K | -793.35%-6.25K | -3.48K | -69.97%21.55K | 107.54%20.98K |
| Gain on sale of security | -408.40%-8.6K | 80.40%-1.23K | -439.42%-18.79K | -169.09%-12.76K | -107.00%-1.33K | -363.29%-1.69K | -3,011.44%-6.25K | ---3.48K | -35.76%18.47K | 106.80%19.04K |
| Other non-operating income (expenses) | --3.34K | --1.22K | --108 | -19,253.67%-589.55K | ---- | ---- | ---- | ---- | -92.84%3.08K | 17.79%1.95K |
| Income before tax | -13.84%-2.77M | -43.50%-3.76M | -174.67%-3.78M | 5.59%-8.85M | 18.11%-2.42M | -40.13%-2.43M | -2.29%-2.62M | 35.10%-1.38M | 22.95%-9.37M | 28.17%-2.95M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -13.84%-2.77M | -43.50%-3.76M | -174.67%-3.78M | 5.59%-8.85M | 18.11%-2.42M | -40.13%-2.43M | -2.29%-2.62M | 35.10%-1.38M | 22.95%-9.37M | 28.17%-2.95M |
| Net income continuous operations | -13.84%-2.77M | -43.50%-3.76M | -174.67%-3.78M | 5.59%-8.85M | 18.11%-2.42M | -40.13%-2.43M | -2.29%-2.62M | 35.10%-1.38M | 22.95%-9.37M | 28.17%-2.95M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -13.84%-2.77M | -43.50%-3.76M | -174.67%-3.78M | 5.59%-8.85M | 18.11%-2.42M | -40.13%-2.43M | -2.29%-2.62M | 35.10%-1.38M | 22.95%-9.37M | 28.17%-2.95M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -13.84%-2.77M | -43.50%-3.76M | -174.67%-3.78M | 5.59%-8.85M | 18.11%-2.42M | -40.13%-2.43M | -2.29%-2.62M | 35.10%-1.38M | 22.95%-9.37M | 28.17%-2.95M |
| Diluted earnings per share | 73.33%-0.04 | 53.33%-0.07 | 11.11%-0.08 | 28.77%-0.52 | 47.83%-0.12 | -50.00%-0.15 | 25.00%-0.15 | 55.00%-0.09 | 43.85%-0.73 | 42.50%-0.23 |
| Basic earnings per share | 73.33%-0.04 | 53.33%-0.07 | 11.11%-0.08 | 28.77%-0.52 | 47.83%-0.12 | -50.00%-0.15 | 25.00%-0.15 | 55.00%-0.09 | 43.85%-0.73 | 42.50%-0.23 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.